Previous Section
Clinical Trials
1. Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study.
- Author
- Salvi M; Vannucchi G; Campi I; Curro N; Dazzi D; Simonetta S; Bonara P; Rossi S; Sina C; Guastella C; Ratiglia R; Beck-Peccoz P;
- Institution
- Department of Medical Sciences, University of Milan, Fondazione Ospedale Maggiore IRCCS, Milan, Italy.
- Journal
- Eur J Endocrinol. 2007 Jan;156(1):33-40.
- Abstract URL
- Click here to view abstract
2. Thyroid hormone state and quality of life at long-term follow-up after randomized treatment of Graves' disease.
- Author
- Abraham-Nordling M; Wallin G; Lundell G; Torring O;
- Institution
- Department of Surgery, Institution of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden. mirna.nordling@ds.se
- Journal
- Eur J Endocrinol. 2007 Feb;156(2):173-9.
- Abstract URL
- Click here to view abstract
3. Clinical and endocrine features and long-term outcome of Graves' disease in early childhood.
- Author
- Bossowski AT; Reddy V; Perry LA; Johnston LB; Banerjee K; Blair JC; Savage MO;
- Institution
- Department of Paediatric Endocrinology Barts and London School of Medicine and Dentistry, London, UK.
- Journal
- J Endocrinol Invest. 2007 May;30(5):388-92.
- Abstract URL
- Click here to view abstract
4. Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study.
- Author
- van Geest RJ; Sasim IV; Koppeschaar HP; Kalmann R; Stravers SN; Bijlsma WR; Mourits MP;
- Institution
- Donders Institute of Ophthalmology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. r.j.vangeest@amc.uva.nl
- Journal
- Eur J Endocrinol. 2008 Feb;158(2):229-37.
- Abstract URL
- Click here to view abstract
5. Anticlastogenic effect of Ginkgo biloba extract in Graves' disease patients receiving radioiodine therapy.
- Author
- Dardano A; Ballardin M; Ferdeghini M; Lazzeri E; Traino C; Caraccio N; Mariani G; Barale R; Monzani F;
- Institution
- Department of Internal Medicine, University of Pisa, via Roma 67-56126 Pisa, Italy.
- Journal
- J Clin Endocrinol Metab. 2007 Nov;92(11):4286-9. Epub 2007 Aug 21.
- Abstract URL
- Click here to view abstract
6. Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: results of a prospective study.
- Author
- Eschmann SM; Thelen MH; Dittmann H; Bares R;
- Institution
- University of Tuebingen, Department of Nuclear Medicine, Germany. susanne-martina.eschmann@med.uni-tuebingen.de
- Journal
- Exp Clin Endocrinol Diabetes. 2006 May;114(5):222-6.
- Abstract URL
- Click here to view abstract
7. Slow-release lanreotide in Graves' ophthalmopathy: A double-blind randomized, placebo-controlled clinical trial.
- Author
- Chang TC; Liao SL; Chang TC; Liao SL;
- Institution
- Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. tcchang@ha.mc.ntu.edu.tw
- Journal
- J Endocrinol Invest. 2006 May;29(5):413-22.
- Abstract URL
- Click here to view abstract
8. Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study.
- Author
- Cappelli C; Gandossi E; Castellano M; Pizzocaro C; Agosti B; Delbarba A; Pirola I; De Martino E; Rosei EA;
- Institution
- Department of Medical and Surgical Sciences, Internal Medicine and Endocrinology Unit, University of Brescia, Italy.
- Journal
- Endocr J. 2007 Dec;54(5):713-20. Epub 2007 Aug 3.
- Abstract URL
- Click here to view abstract
9. Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy.
- Author
- Kahaly GJ; Pitz S; Hommel G; Dittmar M; Kahaly GJ; Pitz S; Hommel G; Dittmar M;
- Institution
- Department of Medicine I, University Hospital, Mainz 55101, Germany, gkahaly@mail.uni-mainz.de
- Journal
- J Clin Endocrinol Metab. 2005 Sep;90(9):5234-40. Epub 2005 Jul 5.
- Abstract URL
- Click here to view abstract
10. A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy.
- Author
- Perros P; Kendall-Taylor P; Neoh C; Frewin S; Dickinson J; Perros P; Kendall-Taylor P; Neoh C; Frewin S; Dickinson J;
- Institution
- Endocrine Unit, Freeman Hospital, Freeman Road, Newcastle upon Tyne NE7 7DN, United Kingdom. petros.perros@ncl.ac.uk
- Journal
- J Clin Endocrinol Metab. 2005 Sep;90(9):5321-3. Epub 2005 Jun 28.
- Abstract URL
- Click here to view abstract
Next: Radioiodine Therapy
